{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:22Z","timestamp":1780984762426,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08095-x","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:28:20Z","timestamp":1775680100000},"page":"2995-3004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential of CAR-T cell immunotherapy in rheumatoid arthritis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8602-0958","authenticated-orcid":false,"given":"Ian C.","family":"Chikanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-3314","authenticated-orcid":false,"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"8095_CR1","doi-asserted-by":"crossref","unstructured":"Chikanza IC (1996) The neuroendocrine immunology of rheumatoid arthritis. In \u201cThe neuroendocrine immune basis of rheumatic diseases\u201d, Edited by Chikanza IC, Balliere's Clinical Rheumatology 10(2):273\u2013294","DOI":"10.1016\/S0950-3579(96)80018-5"},{"key":"8095_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/art.1780351107","volume":"35","author":"IC Chikanza","year":"1992","unstructured":"Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS (1992) Defective hypothalamic responses to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 35:1281\u20131288","journal-title":"Arthritis Rheum"},{"issue":"23","key":"8095_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205\u20132219","journal-title":"N Engl J Med"},{"key":"8095_CR4","doi-asserted-by":"publisher","unstructured":"Chikanza IC, Trollip S, Sakkas LI (2014) Regulatory T cells and autoimmunity. In: Mitesh Kumar Dwivedi, DeLisa Fairweather (eds) Regulatory T cells and autoimmune diseases, Academic Pres, pp 41\u201356. https:\/\/doi.org\/10.1016\/B978-0-443-13947-5.00007-5","DOI":"10.1016\/B978-0-443-13947-5.00007-5"},{"key":"8095_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102397","volume":"18","author":"S Tardito","year":"2019","unstructured":"Tardito S, Martinelli G, Soldano S, Paolino S, Pacini G, Patane M, Alessandri E, Smith V, Cutolo M (2019) Macrophage M1\/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmun Rev 18:102397. https:\/\/doi.org\/10.1016\/j.autrev.2019.102397","journal-title":"Autoimmun Rev"},{"key":"8095_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj1252","volume":"10","author":"MM Hanlon","year":"2024","unstructured":"Hanlon MM, Smith CM, Canavan M, Neto NGB et al (2024) Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset. Sci Adv 10:eadj1252","journal-title":"Sci Adv"},{"issue":"10","key":"8095_CR7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrrheum.2015.79","volume":"11","author":"JS Gregory","year":"2015","unstructured":"Gregory JS, Smolen JS (2015) The role of B-cells in rheumatoid arthritis. Nat Rev Rheumatol 11(10):573\u2013586","journal-title":"Nat Rev Rheumatol"},{"issue":"13","key":"8095_CR8","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA"},{"issue":"8","key":"8095_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F M\u00fcller","year":"2024","unstructured":"M\u00fcller F et al (2024) CD19 CAR-T cell therapy in severe autoimmune diseases: safety and clinical outcomes. N Engl J Med 390(8):687\u2013700","journal-title":"N Engl J Med"},{"issue":"1","key":"8095_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1706169","volume":"379","author":"CH June","year":"2018","unstructured":"June CH, Sadelain M (2018) Chimeric antigen receptor therapy. N Engl J Med 379(1):64\u201373","journal-title":"N Engl J Med"},{"issue":"5","key":"8095_CR11","first-page":"226","volume":"14","author":"Y Morita","year":"2018","unstructured":"Morita Y, Fujio K, Yamamoto K (2018) Therapeutic applications of CAR t-cell technology in autoimmune diseases. Nat Rev Rheumatol 14(5):226\u2013237","journal-title":"Nat Rev Rheumatol"},{"key":"8095_CR12","volume":"12","author":"Y Fu","year":"2021","unstructured":"Fu Y, Wang F, Zhang X (2021) CAR t-cell therapy targeting macrophages in autoimmune diseases. Front Immunol 12:698423","journal-title":"Front Immunol"},{"issue":"5","key":"8095_CR13","first-page":"682","volume":"80","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) CD19 CAR t-cells in the treatment of autoimmune diseases. Ann Rheum Dis 80(5):682\u2013689","journal-title":"Ann Rheum Dis"},{"key":"8095_CR14","volume":"110","author":"MD Levin","year":"2020","unstructured":"Levin MD, Chen G (2020) CD19 CAR T-cells in autoimmune diseases: promise and potential risks. J Autoimmun 110:102420","journal-title":"J Autoimmun"},{"issue":"7","key":"8095_CR15","first-page":"803","volume":"21","author":"M Xie","year":"2020","unstructured":"Xie M, Liu J (2020) Targeting citrullinated peptides with CAR T-cells in autoimmune diseases. Nat Immunol 21(7):803\u2013811","journal-title":"Nat Immunol"},{"issue":"5","key":"8095_CR16","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.2353\/ajpath.2007.070004","volume":"171","author":"CN Tran","year":"2007","unstructured":"Tran CN, Lundy SK, White PT, Endres JL, Motyl CD, Gupta R et al (2007) Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells. Am J Pathol 171(5):1588\u201398. https:\/\/doi.org\/10.2353\/ajpath.2007.070004","journal-title":"Am J Pathol"},{"issue":"5","key":"8095_CR17","first-page":"134","volume":"43","author":"L Liu","year":"2020","unstructured":"Liu L, Wang M, Li Q (2020) B-cell depletion using CAR T-cells: a new approach to treating autoimmune diseases. J Immunother 43(5):134\u2013144","journal-title":"J Immunother"},{"issue":"7","key":"8095_CR18","first-page":"414","volume":"16","author":"FM Brennan","year":"2020","unstructured":"Brennan FM, McInnes IB (2020) Ra: mechanisms of disease and therapeutic targeting. Nat Rev Rheumatol 16(7):414\u2013426","journal-title":"Nat Rev Rheumatol"},{"issue":"15","key":"8095_CR19","first-page":"1707","volume":"130","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS et al (2018) Chimeric antigen receptor T-cell therapy: safety and efficacy in hematologic cancers. Blood 130(15):1707\u20131717","journal-title":"Blood"},{"key":"8095_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/annrheumdis-2020217844","volume":"80","author":"B Zhang","year":"2021","unstructured":"Zhang B, Wang Y, Yuan Y, Sun J, Liu L, Huang D et al (2021) In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells. Ann Rheum Dis 80:176\u2013184. https:\/\/doi.org\/10.1136\/annrheumdis-2020217844","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8095_CR21","first-page":"1713","volume":"181","author":"KA Hay","year":"2020","unstructured":"Hay KA, Gauthier J (2020) The cost and manufacturing challenges of CAR T-cell therapy. Cell 181(7):1713\u20131727","journal-title":"Cell"},{"key":"8095_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1502712","volume":"15","author":"C Rangel-Pel\u00e1ez","year":"2024","unstructured":"Rangel-Pel\u00e1ez C, Mart\u00ednez-Guti\u00e9rrez L, Trist\u00e1n-Manzano M et al (2024) CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases? Front Immunol 15:1502712. https:\/\/doi.org\/10.3389\/fimmu.2024.1502712","journal-title":"Front Immunol"},{"issue":"6","key":"8095_CR23","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1093\/rheumatology\/keaf077","volume":"64","author":"FN Albach","year":"2025","unstructured":"Albach FN, Minopoulou I, Wilhelm A et al (2025) Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritis. Rheumatology 64(6):4075\u20134077. https:\/\/doi.org\/10.1093\/rheumatology\/keaf077","journal-title":"Rheumatology"},{"key":"8095_CR24","unstructured":"Juno Therapeutics, Inc (n.d.) A study of healthy donor CD19-targeted allogeneic CAR T cells in participants with severe, refractory autoimmune diseases. ClinicalTrials.gov Identifier: NCT07115745. https:\/\/clinicaltrials.gov\/study\/NCT07115745"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08095-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08095-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08095-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:25:00Z","timestamp":1780982700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08095-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8095"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08095-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}